ZimVie (NASDAQ:ZIMV) Issues Earnings Results, Beats Expectations By $0.02 EPS

ZimVie (NASDAQ:ZIMVGet Free Report) posted its quarterly earnings results on Wednesday. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.02, Zacks reports. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. The firm had revenue of $111.52 million for the quarter, compared to analyst estimates of $113.67 million. ZimVie updated its FY 2025 guidance to 0.800-0.950 EPS.

ZimVie Trading Down 5.7 %

Shares of ZimVie stock traded down $0.75 during trading on Thursday, hitting $12.36. The stock had a trading volume of 68,397 shares, compared to its average volume of 248,449. The stock has a 50 day simple moving average of $13.77 and a 200 day simple moving average of $14.79. The company has a quick ratio of 1.38, a current ratio of 1.94 and a debt-to-equity ratio of 0.57. ZimVie has a 1 year low of $12.26 and a 1 year high of $22.40. The company has a market capitalization of $340.99 million, a PE ratio of -0.94 and a beta of 2.10.

Analyst Ratings Changes

Separately, Needham & Company LLC reaffirmed a “buy” rating and set a $23.00 target price on shares of ZimVie in a report on Thursday.

Get Our Latest Research Report on ZIMV

ZimVie Company Profile

(Get Free Report)

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

Featured Stories

Earnings History for ZimVie (NASDAQ:ZIMV)

Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.